Sofie Company Profile
What is the competitive landscape for SOFIE
SOFIE has eight approved drugs.
Drugs and US Patents for Sofie
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sofie | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 203592-001 | Aug 18, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofie | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203543-001 | Dec 14, 2012 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofie | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 204463-001 | Oct 21, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofie | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 203544-001 | Dec 26, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sofie | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204465-001 | Oct 23, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofie | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203665-001 | Feb 14, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

